F/m Emerald Life Sciences Innovation ETF(LFSC · ETF)
ETF quote, holdings, sector allocation, technicals, and options analytics.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
F/m Emerald Life Sciences Innovation ETF (LFSC) ETF
- Exchange
- XNAS
- Inception
- 2024-10-30
- Has Options
- No
| # | Symbol | Issuer | Weight | Value |
|---|---|---|---|---|
| 1 | Cogent Biosciences Inc | Cogent Biosciences Inc | 9.05% | $8.7M |
| 2 | LivaNova PLC | LivaNova PLC | 7.36% | $7.0M |
| 3 | TransMedics Group Inc | TransMedics Group Inc | 5.26% | $5.0M |
| 4 | Mirum Pharmaceuticals Inc | Mirum Pharmaceuticals Inc | 4.84% | $4.6M |
| 5 | Travere Therapeutics Inc | Travere Therapeutics Inc | 4.63% | $4.4M |
| 6 | Spyre Therapeutics Inc | Spyre Therapeutics Inc | 4.41% | $4.2M |
| 7 | United Therapeutics Corp | United Therapeutics Corp | 4.35% | $4.2M |
| 8 | Guardant Health Inc | Guardant Health Inc | 4.32% | $4.1M |
| 9 | WaVe Life Sciences Ltd | WaVe Life Sciences Ltd | 4.21% | $4.0M |
| 10 | Savara Inc | Savara Inc | 4.04% | $3.9M |
| 11 | KalVista Pharmaceuticals Inc | KalVista Pharmaceuticals Inc | 3.81% | $3.6M |
| 12 | Nektar Therapeutics | Nektar Therapeutics | 3.61% | $3.5M |
| 13 | ICU Medical Inc | ICU Medical Inc | 3.03% | $2.9M |
| 14 | Trevi Therapeutics Inc | Trevi Therapeutics Inc | 2.84% | $2.7M |
| 15 | Bridgebio Pharma Inc | Bridgebio Pharma Inc | 2.56% | $2.5M |
| 16 | ACADIA Pharmaceuticals Inc | ACADIA Pharmaceuticals Inc | 2.44% | $2.3M |
| 17 | Integer Holdings Corp | Integer Holdings Corp | 2.18% | $2.1M |
| 18 | Axsome Therapeutics Inc | Axsome Therapeutics Inc | 2.15% | $2.1M |
| 19 | Collegium Pharmaceutical Inc | Collegium Pharmaceutical Inc | 2.06% | $2.0M |
| 20 | Madrigal Pharmaceuticals Inc | Madrigal Pharmaceuticals Inc | 1.76% | $1.7M |
| 21 | Ceribell Inc | Ceribell Inc | 1.70% | $1.6M |
| 22 | Globus Medical Inc | Globus Medical Inc | 1.60% | $1.5M |
| 23 | Corcept Therapeutics Inc | Corcept Therapeutics Inc | 1.52% | $1.4M |
| 24 | Waystar Holding Corp | Waystar Holding Corp | 1.46% | $1.4M |
| 25 | Lumexa Imaging Holdings Inc | Lumexa Imaging Holdings Inc | 1.38% | $1.3M |
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +4.48% | 2 |
| Feb | -3.63% | 2 |
| Mar | -3.83% | 2 |
| Apr | +6.92% | 2 |
| May | +1.36% | 2 |
| Jun | +0.09% | 2 |
| Jul | -1.57% | 1 |
| Aug | -0.39% | 1 |
| Sep | +6.22% | 1 |
| Oct | +5.49% | 2 |
| Nov | +10.34% | 2 |
| Dec | -6.19% | 2 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Enter a ticker to render the implied volatility surface.
- Beta (1Y vs SPY)
- 1.28
- Correlation (SPY)
- 59.2%
- R²
- 0.35
- Ann. Volatility
- 26.3%
- SPY Volatility
- 12.1%
High volatility - stock moves more than market
Click any bar to view the full quote for that stock.
| Symbol | Price | 1 Day | 1 Week | 1 Month |
|---|